Alcohol
21
3
3
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
4.8%
1 terminated out of 21 trials
91.7%
+5.2% vs benchmark
0%
0 trials in Phase 3/4
45%
5 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (21)
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study
Evaluation of a Sexual Violence and Intimate Partner Violence Primary Prevention Program Implemented in Drinking Establishments
Testing Alcohol Cancer Risk Messages
Investigating the Effects of Calorie Information and Serving Size of Alcohol Products on Alcohol Consumption.
Social Media Psychosocial Support Group in Reducing Alcohol Consumption
Decisions During Drinking
Social Support Intervention for Addiction Recovery
Tirzepatide for Alcohol Use Disorder
Piloting a Biomarker-augmented Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) Program Among HIV-affected Adolescents and Young Adults in Zambia
Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients
Substance Consumption, Personality, and Cognitive Functioning of Chess Players
Radiofrequency Applications and Alcoholic Neurolysis of Genicular Nerve for the Treatment of Knee Osteoarthritic Pain
Rapid BAC Reduction with Nutraceutical Blend Study
A Phase I Study of the Interaction of Alcohol With Oral AFA-281 in Healthy Volunteers
Michigan SPARC Trial
Families With Substance Use and Psychosis: A Pilot Study
A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects
The HOLIDAY (HOw ALcohol InDuces Atrial TachYarrhythmias) Study
Intermittent Naltrexone Among Polysubstance Users